or Try an Advanced Search...

    Influenza Vaccine Stocks List

    Symbol Grade Name % Change
    NVAX B Novavax, Inc. 13.68
    IBIO C iBio, Inc. 8.59
    OPK D OPKO Health Inc. 0.00
    INO D Inovio Pharmaceuticals, Inc. -7.42
    VBIV D VBI Vaccines Inc. 1.37
    ABT F Abbott Laboratories -0.85
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic Medical Devices
    Related Stock Lists: Influenza Medicine Infectious Diseases Vaccination Vaccines Cancer Avian Influenza Biopharmaceutical Biotechnology Coronavirus Pharmaceutical Products Prostate Cancer Seasonal Influenza Seasonal/Pandemic Influenza Thyroid Vascular Products Virology Active Pharmaceutical Ingredients Alzheimer's Disease Angioedema

    Related ETFs - A few ETFs which own one or more of the above listed Influenza Vaccine stocks.

    Symbol Grade Name Weight
    IHI C iShares U.S. Medical Devices ETF 15.95
    PJP A PowerShares Dynamic Pharmaceuticals 5.08
    GERM C ETFMG Treatments Testing and Advancements ETF 4.6
    HART B IQ Healthy Hearts ETF 4.33
    VIRS A Pacer BioThreat Strategy ETF 4.24
    View all Influenza Vaccine ETFs...
    Compare ETFs
    Compare HART to VIRS Compare IHI to VIRS Compare PJP to HART

        Influenza Vaccine Stocks Recent News

        Date Stock Title
        May 20 OPK $3.5M Bet On This Healthcare Stock? Check Out These 3 Penny Stocks Insiders Are Aggressively Buying
        May 20 NVAX Shah Capital ends campaign against Novavax board after Sanofi deal
        May 20 NVAX Shah Capital Withdraws Proxy Campaign Against Re-Election of Directors at Novavax’s 2024 Annual Meeting
        May 19 NVAX This Stock Just More Than Doubled in 1 Day: Is It a Buy?
        May 18 NVAX Is Novavax Stock a Buy?
        May 18 ABT Abbott Laboratories: Buying More Of This Top-Notch Dividend Growth Stock
        May 17 ABT Abbott (ABT) Down 0.4% Since Last Earnings Report: Can It Rebound?
        May 17 NVAX The Zacks Analyst Blog Highlights Novavax, Sanofi, Fulcrum Therapeutics, Moderna and Bristol Myers
        May 17 NVAX Could Novavax Become the Next Moderna?
        May 16 NVAX Biotech Stock Roundup: NVAX, FULC Up on Deals With SNY, Updates From MRNA, BMY
        May 16 NVAX If You'd Invested $10,000 in Novavax a Year Ago, This Is How Much You'd Have Now
        May 16 ABT These Dividend Stocks Are an Investor's Best Friend
        May 15 ABT Tudor Investment's top buys and sells in Q1
        May 15 VBIV VBI Vaccines GAAP EPS of -$0.73 misses by $0.20, revenue of $1.21M misses by $1.64M
        May 15 VBIV VBI Vaccines Reports First Quarter 2024 Financial Results
        May 15 NVAX 1 Wall Street Analyst Thinks Novavax Stock Is Going to $10. Is It a Sell?
        May 15 INO Inovio Pharmaceuticals, Inc. (INO) Presents at 2024 RBC Capital Markets Global Healthcare Conference (Transcript)
        May 15 ABT Abbott recalls HeartMate 3 over potential blood leakage, air issues
        May 15 NVAX 2 Incredible Growth Stocks to Buy Hand Over Fist Right Now
        May 15 ABT Abbott recalls Heartmate pump after 70 injuries, 2 deaths reported
        Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic Medical Devices
        Related Stock Lists: Influenza Medicine Infectious Diseases Vaccination Vaccines Cancer Avian Influenza Biopharmaceutical Biotechnology Coronavirus Pharmaceutical Products Prostate Cancer Seasonal Influenza Seasonal/Pandemic Influenza Thyroid Vascular Products Virology Active Pharmaceutical Ingredients Alzheimer's Disease Angioedema
        Influenza Vaccine

        The influenza vaccine, also known as the flu shot, is an annual vaccine given to protect against the influenza virus. It is made from inactivated (killed) viruses and is given as an injection into the muscle. The vaccine helps the body develop immunity to the virus, so that if a person is exposed to the virus, their body can fight it off.

        Browse All Tags